Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
17.14
-0.13 (-0.78%)
Jun 11, 2025, 2:50 PM - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.64 billion as of June 11, 2025. Its market cap has increased by 63.80% in one year.
Market Cap
5.64B
Enterprise Value
5.56B
1-Year Change
63.80%
Ranking
Category
Stock Price
17.14
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $5.64B, an increase of 4,791.88%. That is a compound annual growth rate of 67.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.42B |
| Johnson & Johnson | 374.75B |
| Novo Nordisk | 353.20B |
| AbbVie | 338.07B |
| UnitedHealth Group | 280.60B |
| Abbott Laboratories | 233.68B |
| Novartis AG | 232.35B |
| AstraZeneca | 227.75B |